Gene Knockdown targeting ACLY not only exhibited potent inhibitory effects on the proliferation, migration and invasion of HCC cells, but also effectively overcame sorafenib resistance, particularly under hypoxic conditions (59, 60). The gene discussed is ACLY; the disease is hepatocellular carcinoma.